Forsbach G, Olivares F, Vázquez J, Güitrón A
Hospital de Gineco-Obstetricia Dr. I. Morones, IMSS Monterrey, Depto. de Endocrinología.
Ginecol Obstet Mex. 1998 Apr;66:170-2.
A young woman with amenorrhea-galactorrhea induced by a prolactin (PRL) secreting pituitary macroadenoma, was treated with bromocriptine 5 mg/day per os. Serum PRL levels were normal at 6 weeks and menstruation appeared at 8 weeks of treatment. When twenty months of treatment were completed, a tomographic study of the pituitary was unable to show any enlargement. Controversies related to macroprolactinomas treatment are discussed and it is suggested that treatment with dopamine agonists must be the elective treatment for patients with macroprolactinoma.
一名因分泌催乳素(PRL)的垂体大腺瘤导致闭经-溢乳的年轻女性,接受了每日口服5毫克溴隐亭的治疗。治疗6周时血清PRL水平恢复正常,治疗8周时月经来潮。治疗满20个月时,垂体断层扫描未显示任何增大。文中讨论了与垂体大腺瘤治疗相关的争议,并提出多巴胺激动剂治疗应为垂体大腺瘤患者的首选治疗方法。